Do you want to read an article? Please log in or register.
A thirty year clinical and MRI observational study of multiple sclerosis and clinically isolated syndromes
Multiple Sclerosis
Related content
Multiple Sclerosis
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study
Lancet Neurol.
Filippi M, Preziosa P, Meani A, Ciccarelli O, Mesaros S, Rovira A, Frederiksen J, Enzinger C, Barkhof F, Gasperini C, Brownlee W, Drulovic J, Montalban X, Cramer SP, Pichler A, Hagens M, Ruggieri S, Martinelli V, Miszkiel K, Tintorè M, Comi G, Dekker I, Uitdehaag B, Dujmovic-Basuroski I, Rocca MA
doi: 10.1016/
Multiple Sclerosis
Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
N Engl J Med.
Metz LM, Li DKB, Traboulsee AL, Duquette P, Eliasziw M, Cerchiaro G1, Greenfield J, Riddehough A, Yeung M, Kremenchutzky M, Vorobeychik G, Freedman MS, Bhan V, Blevins G, Marriott JJ, Grand'Maison F, Lee L, Thibault M, Hill MD, Yong VW; Minocycline in MS Study Team
doi: 10.1056/NEJMoa1608889.
Multiple Sclerosis
Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome
JAMA Neurol.
van der Vuurst de Vries RM, Mescheriakova JY, Wong YYM, Runia TF, Jafari N, Samijn JP, de Beukelaar JWK, Wokke BHA, Siepman TAM, Hintzen RQ
doi: 10.1001/jamaneurol.
RECOMMENDED
Multiple Sclerosis
Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event
★ 3
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Ann Neurol.
Lebrun-Frenay C, Kantarci O, Siva A, Sormani MP, Pelletier D, Okuda DT, 10-year RISC study group on behalf of SFSEP, OFSEP.
doi: 10.1002/ana.25799.
Aging and Cognitive FunctionsMultiple Sclerosis
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)
J Neurol.
Comi G, Patti F, Rocca MA, Mattioli FC, Amato MP, Gallo P, Centonze D, Pozzilli C, Saccà F, Bergh FT, Bartezaghi M, Turrini R, Filippi M; Golden Study Group
doi: 10.1007/s00415-017-8642-5.
SPECIAL REPORT
Multiple Sclerosis
Long-Term Real-World Use of Natalizumab Over 10 Years in Relapsing-Remitting Multiple Sclerosis
RECOMMENDED
Multiple Sclerosis
Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
Mult Scler.
Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D, Kropshofer H, Fuchs TA, Barro C, Leppert D, Yaldizli Ö, Kuhle J, Benedict RH
doi: 10.1177/1352458519881428.
RECOMMENDED
Multiple Sclerosis
Optical coherence tomography: a window to the optic nerve in clinically isolated syndrome
Brain.
London F, Zéphir H, Drumez E, Labreuche J, Hadhoum N, Lannoy J, Hodel J, Vermersch P, Pruvo JP, Leclerc X,
Outteryck O
doi: 10.1093/
RECOMMENDED
Multiple Sclerosis
Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational study
Ther Adv Neurol Disord.
Kallmann BA, Tiel-Wilck K, Kullmann JS, Engelmann U, Chan A
doi: 10.1177/